Asset
CEFILAVANCIN
Theravance Biopharma Inc. Ordinary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00442832 | phase2 | completed | 2006-12-01 | 2007-05-01 | Theravance Biopharma | TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection |
FDA applications (0)
This company has no applications containing this asset.